Pharmaceutical Filtration Market

The global pharmaceutical filtration market is projected to reach USD 13.31 billion in 2024 will increase to USD 20.97 billion by 2029, with a compound annual growth rate (CAGR) of 9.5% from 2024 to 2029. The growth of pharmaceutical filtration market ascribed to major factors such as  growing R&D spendings in biopharmaceutical industries, increasing  adoption of continuous manufacturing process, and rising need of purity requirements in pharmaceutical & biotechnology manufacturing. On the other hand, membrane fouling and breakage issues and technical limitations are projected to impede market growth.

Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany) holding the significant global market share and the global pharmaceutical filtration market is highly cosolidated.

To know about the assumptions considered for the study download the pdf brochure

Merck KGaA (Germany)

Merck KGaA dominated the pharmaceutical filtration market in 2023. Merck KGaA is a leading life science company offering wide range of pharmaceutical filtration products. The company operates through three business segments such as Healthcare, Life Science, and Performance Material. The Process Solutions business unit comes under Life Science segment, sells products and services for the pharmaceutical production. The substantial contribution and continuous growth of this segment primarily owe to the powerful product portfolio, brand recognition, and heightened demand for bioprocessing technologies, including filtration products from bioprocessing business units, especially in the region of Asia Pacific and North America.

Danaher Corporation (US)

Danaher is one of the leading player in pharmaceutical filtration market. the company offers wide range of pharmaceutical filtration solutions such as membranes, syringe filters, vacuum devices, and large-molecular capsules. Thus, broad product portfolio and strong distribution network across the world, help Danaher to compete in the market. Furthermore, the company focuses of adoption of  organic growth strategies such as manufacturing facility expansion and capacity expansion to increase its presence in the global market. For instance, in October 2023, Cytiva, a life sciences business subsidiary of Danaher, set up unit in India to get closer to biopharma customers with an investment of around USD 3 million.

Sartorius AG (Germany)

Sartorius AG offers wide range of pharmaceutical filtration products for end users such as biopharmaceutical & pharmaceutical companies, CMOs, and CROs. The company focuses on significant investment in R&D to launch products including Sartolab RF|BT Vacuum Filtration Units for pharmaceutical filtration applications. Sartorius has actively adopted strategic expansions to fulfil the demand for its products. For instance, in recent years, the company increased its geographic presence across China, the UK, South Korea, the US, Puerto Rico, and France through the establishment and expansion of manufacturing facilities and customer interaction centers to support the significant global demand for pharmaceutical filtration products. The company is expected to show high growth in the pharmaceutical filtration market during the forecast period.

Related Reports:

Pharmaceutical Filtration Market by Product (Consumables (Membrane, Depth filter), System (Single use, Reusable)), Technique (Microfiltration, Ultrafiltration), Application (API, Protein, Vaccine), Scale of Operation (Pilot, R&D) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]